Not many people get excited about revisions and updates to the very dry National Institute of Standards and Technology (“NIST”) handbooks. For example, the NIST 44 Handbook contains the “Specifications, Tolerances, and Other Technical Requirements for Weighing and Measuring Devices.” The handbooks are adopted every year at the annual National Conference on Weights and Measures
As the international trade of cannabis gets closer to a reality, it will become important for companies in the cannabis industry to better understand how U.S. trade laws can be used by domestic producers to try to protect their US market position against import competition. Similarly, US importers and foreign producers and exporters may soon need to understand how AD/CVD cases can disrupt any plans to export to the US market and what options they may have to respond to such actions.
Last week, the Supreme Court of South Dakota overturned a voter-approved, constitutional amendment to legalize adult use cannabis statewide. Governor Kristi Noem instigated the anti-democratic fight on social welfare grounds, although the court made its ruling on technical grounds, finding that Amendment A violated a “single-issue” initiative subject requirement. If that’s true, you’d have to
Socially responsible and “sustainable” investing is picking up in popularity across retail and institutional investors alike. According to Wikipedia, “[i]n less than 20 years, the ESG movement has grown from a corporate social responsibility initiative launched by the United Nations into a global phenomenon representing more than US$30 trillion in assets under management.” When it
Last Friday, I spoke on a panel for the American Bar Association (ABA) in Denver. It was the first conference for the ABA’s new Global Cannabis section and the first live event I’ve done since COVID started. The panel discussed “Legal Ethics in International Cannabis.” My colleague Adams Lee participated too, but on another panel
I feel like we’re living in an upside down world when it comes to cannabis legalization at the federal level. The main reason being that Dems, despite in being in full control of Congress and the White House, just can’t get the ball across the line on a number of cannabis reform bills. This includes
On the 25th anniversary of Prop. 215, I was recently interviewed on KCRW to give my take on how California (and specifically the City of Los Angeles) has done when it comes to legalizing and licensing cannabis businesses. I’m a pretty tough critic of California in general if you read any of my writings on
When it comes to medical cannabis, Israel has long been among the leading nations in the world. You can read a post I wrote about Israel’s achievements on that front, both in terms of legality and actual research, here. But despite its deep history with medical cannabis, the country still does not permit legal sales
Some readers may be surprised to realize that a lot of cannabis stakeholders actually don’t want broadsweeping federal legalization. Why? Because they know it means that they’ll instantly be competing with well-established companies that are already masters of economies of scale, branding, marketing, and consumer sales, and their market share will shrink or be eliminated
Listen HERE or stream on Spotify, Apple Podcasts, Amazon Music, Stitcher, or Soundcloud! At Harris Sliwoski, we keep close tabs on what is happening around the world, and we know that our friends and clients do, as well. We are happy to provide this podcast series: Global Law and Business, hosted by international attorneys Fred Rocafort and Jonathan Bench, where we look at
